News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoStem, Inc.'s Vice President, Clinical Development and Regulatory Affairs, to Present at MSC2013


8/15/2013 9:50:10 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Aug. 15, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, announced today that Jonathan Sackner-Bernstein, MD, FACC, Vice President, Clinical Development and Regulatory Affairs of NeoStem, has been invited to present at an industry conference next week on the topic of AMR-001, the Company's lead product candidate, in a talk titled "CD34 Stem Cells: Biology's Blueprint for Optimized Interventional Cardiology".

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES